News | May 23, 2023
Sun Pharma Advanced Research Company posts Q4 FY23 loss at Rs. 81.99 Cr
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Fully equipped labs with 75-member team set-up and made operational in <100 days
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells
To enable company to be future-ready by tapping potential in CDMO space
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
Subscribe To Our Newsletter & Stay Updated
